ISG15 and colorectal carcinoma: The induction in ISG15 by L1 was dependent on the NF-κB pathway and ISG15 was detected in CRC tumor tissue and in the adjacent stroma, but not in normal colonic mucosa, suggesting that ISG15 could serve as a therapeutic target for CRC treatment [63].